The technology combines microelectronics and microfluidics to isolate rare cells from mixed cellular samples. Built-in software allows for rapid selection of cells with a high level of accuracy, reproducibility, and image quality. The system is compatible with a variety of rare cell suspensions, including live and fixed cells, small cell loads, formalin-fixed paraffin-embedded (FFPE) tissues, and liquid biopsies.

Additional fluorescent channels provide expanded ability to better characterize different cell populations from complex heterogenous samples. The new DEPArray technology optimizes the user experience, reduces hands-on time, and speeds up sample processing, according to the firm.

The flexible system allows researchers to prepare samples according to their own protocols or use sample preparation kits. DEPArray Plus is fully integrated with blood samples prepared with the Menarini Silicon Biosystems CTC enrichment technologies, CellSearch and CellMag, allowing further isolation and delivery of pure single cells ready for genetic analysis.

Menarini introduces multiple myeloma assay
Menarini Silicon Biosystems has launched the CellSearch Circulating Multiple Myeloma Cells Assay. The new test will assist pharmaceutical companies, contract...

Menarini Silicon launches CellMag product line
Menarini Silicon Biosystems has launched its CellMag product line for the manual enrichment and staining of rare circulating tumor cells.

Microfluidics and Omics Converging to Propel Single-Cell Analysis
Here at The Science Advisory Board, we recognize the study of cells has been instrumental in understanding biological processes. Today’s advancements...